(“Gateway Health”), a leading managed care organization dedicated to caring for the total health of its…
Category: News
Universal Health Realty Income Trust Reports 2021 Second Quarter Financial Results
Universal Health Realty Income Trust announced today that for the three-month period ended June 30, 2021, net…
Loyal’s Natural Wellness Products for Women Designed to Restore Balance to the Whole Body and Elevate Self Care, Now Available at Target
Loyal, a leading natural wellness brand that is obsessed with whole body balance while seeking to…
ALKM – Alkame Announces Ongoing Hand Sanitizer Sales and Recently Enhanced Cost- Effective Production Process Updates
Alkame Holdings, Inc. (OTC PINK: ALKM), a publicly traded holding company is pleased to announce that…
American Nutrition Association New Leadership Structure and Board Members
The American Nutrition Association® (ANA®) announced today its new Board leadership structure and Board Members, effective…
First Choice Health Introduces Direct-to-Employer Healthcare in Partnership with St. Charles Health System and Praxis Health
First Choice Health (FCH), a leading provider-owned health benefits administrator in the Northwest , today announced an…
Steven Ginsburg’s Book and Treatment Center Aims to Help Others Out of Addiction
“You are worth it — all of it. You are loved and you have been chosen.…
Youtheory Launches Daily Fat Burner Designed to Promote Healthy Weight Management
Southern California based supplement company Youtheory® has launched its Daily Fat Burner. This supplement is designed…
Arctic Vision Joins Forces with the University of Hong Kong Department of Ophthalmology to Discover and Develop Novel Neuroprotective Therapies for Ocular Disease
Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pan-ocular diseases, announcing today…
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
TORRANCE, Calif.–(BUSINESS WIRE)–Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the issuance…